📰 Greenlight Bioscience News
Greenlight Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Greenlight Bioscience. Real-time updates on events, politics, business and more.
June 26, 2023
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 275 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare GreenLight Biosciences to similar businesses based on the strength of its profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends. Insider and Institutional Ownership […]
June 26, 2023
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 275 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its competitors? We will compare GreenLight Biosciences to related companies based on the strength of its dividends, profitability, risk, institutional ownership, analyst recommendations, earnings and valuation. Analyst Recommendations This is […]
June 23, 2023
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 263 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare GreenLight Biosciences to related businesses based on the strength of its institutional ownership, analyst recommendations, risk, dividends, profitability, valuation and earnings. Institutional and Insider Ownership […]
June 6, 2023
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 278 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare GreenLight Biosciences to similar businesses based on the strength of its profitability, risk, institutional ownership, dividends, earnings, analyst recommendations and valuation. Earnings and Valuation This […]
June 2, 2023
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 281 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare GreenLight Biosciences to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends. Institutional and […]
May 30, 2023
SHAREHOLDER ALERT: Weiss Law Investigates GreenLight Biosciences Holdings ...
March 21, 2023
/PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Neoantigen Cancer Vaccine Market was valued at more than USD 1.8 billion...
March 21, 2023
NOIDA, India, March 21, 2023 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Neoantigen Cancer Vaccine Market was valued at more than USD 1.8 billion
November 10, 2022
Contract development and manufacturing organization (CDMO) Samsung Biologics is focused on sustainable growth, says CEO John Rim. According to Rim, a key component of this growth will be the CDMO's expanded mRNA vaccine production capabilities, as well as its recent full acquisition of Samsung Bioepis, a biosimilars company that had previously been operated as a joint venture with Biogen.
October 18, 2022
But while the mRNA vaccines have now been approved for human use and have been produced at a global scale during the pandemic, questions remain regarding how mRNA vaccine production will proceed in a post-pandemic future, particularly as new applications of mRNA emerge.